Pemetrexed-Carboplatin Adjuvant Chemotherapy With or Without Gefitinib in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Harbouring EGFR Mutations: A Randomized, Phase II Study

被引:0
作者
Ning Li
Wei Ou
Xiong Ye
Hai-Bo Sun
Liang Zhang
Qin Fang
Song-Liang Zhang
Bao-Xiao Wang
Si-Yu Wang
机构
[1] Sun Yat-sen University Cancer Center,Department of Thoracic Surgery
[2] Guangdong General Hospital,Department of Thoracic Surgery
[3] Henan Cancer Hospital,Department of Thoracic Surgery
[4] Tianjin First Center Hospital,Department of Thoracic Surgery
[5] The Third People’s Hospital of Huizhou,Department of Medical Oncology
[6] Guangzhou Medical University,College of Clinical Medicine
来源
Annals of Surgical Oncology | 2014年 / 21卷
关键词
Overall Survival; Gefitinib; Pemetrexed; EGFR Mutation; Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2091 / 2096
页数:5
相关论文
共 85 条
  • [1] Jemal A(2011)Global cancer statistics CA Cancer J Clin. 61 69-90
  • [2] Bray F(1997)Revisions in the international system for staging lung cancer Chest. 111 1710-1717
  • [3] Center MM(2003)Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer J Natl Cancer Inst. 95 1453-1461
  • [4] Ferlay J(2004)Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med. 350 351-360
  • [5] Ward E(2004)Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 26 173-182
  • [6] Forman D(2005)Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med. 352 2589-2597
  • [7] Mountain CF(2006)Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol. 7 719-727
  • [8] Scagliotti GV(2008)Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol. 26 3552-3559
  • [9] Fossati R(2004)Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy J Clin Oncol. 22 1589-1597
  • [10] Torri V(2008)Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer J Clin Oncol. 26 3543-3551